Injectable Drug Delivery - Global Market Outlook (2017-2026)

   |      |      |  

Injectable Drug Delivery - Global Market Outlook (2017-2026)

Global Injectable Drug Delivery market is expected to grow from $404.14 billion in 2017 to reach $1199.89 billion by 2026 with a CAGR of 12.8%. Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles is hampering the market growth.

Drug delivery is the method of administering a pharmaceutical compound into the body through different routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by passing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. It is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson’s disease, hemophilia, hepatitis C and ribose-5-phosphate isomerase deficiency.

Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition they offer better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.

By Geography, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.

Some of the key players in the Injectable Drug Delivery market include Baxter International, Inc., ELI Lilly and Company, Terumo Corporation, Becton, Dickinson and Company, Pfizer, Inc., Gerresheimer AG, Teva Pharmaceutical Industries Ltd., Schott AG, Sandoz, Antares Pharma, Inc., Zogenix, Inc., Scandinavian Health Limited, Terumo Medical Corp., Ypsomed Holding AG, Unilife Corporation, Vetter Pharma-Fertigung GmbH & Co. KG and Nova Nordisk A/S.

Types Covered:
• Formulations
• Devices

Formulation Packagings Covered:
• Cartridges
• Ampules
• Bottles
• Vials

Usage Patterns Covered:
• Immunization 
• Curative Care 
• Other Usage Patterns

Facility of Uses Covered:
• Home Care Settings
• Hospitals and Clinics
• Other Facilities of Use

Site of Administrations Covered:
• Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
• Skin (Intradermal and Subcutaneous)
• Central Nervous System (Intracerebral and Intrathecal)
• Organs (Intravitreal and Intra-Articular)

Applications Covered:
• Hormonal Disorders
• Autoimmune Diseases
• Cancer
• Orphan Diseases
• Cardiovascular diseases
• Neurology Addiction
• Respiratory Diseases
• Regenerative Medicine
• Oncology
• Other Therapeutic Applications

Distribution Channels Covered:
• Retail Pharmacy Stores
• Hospitals
• E-Commerce

End Users Covered:
• Ambulatory Care
• Home Based
• Clinics/Physician Offices
• Other End Users

Regions Covered:

North America

US
Canada
Mexico

Europe

Germany
UK
Italy
France
Spain
Rest of Europe

Asia Pacific

Japan       
China       
India       
Australia 
New Zealand     
South Korea      
Rest of Asia Pacific   

South America

Argentina
Brazil
Chile
Rest of South America

Middle East & Africa

Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

1 Executive Summary      
        
2 Preface       
 2.1 Abstract      
 2.2 Stake Holders      
 2.3 Research Scope     
 2.4 Research Methodology    
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources   
  2.5.2 Secondary Research Sources   
  2.5.3 Assumptions    
        
3 Market Trend Analysis     
 3.1 Introduction     
 3.2 Drivers      
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats      
 3.6 Application Analysis    
 3.7 End User Analysis     
 3.8 Emerging Markets     
 3.9 Futuristic Market Scenario    
        
4 Porters Five Force Analysis     
 4.1 Bargaining power of suppliers    
 4.2 Bargaining power of buyers    
 4.3 Threat of substitutes    
 4.4 Threat of new entrants    
 4.5 Competitive rivalry     
        
5 Global Injectable Drug Delivery Market, By Type   
 5.1 Introduction     
 5.2 Formulations      
  5.2.1 Novel Drug Delivery Formulations  
   5.2.1.1 Microparticles   
    5.2.1.1.1 Microcapsules  
    5.2.1.1.2 Microspheres  
   5.2.1.2 Colloidal Dispersions   
    5.2.1.2.1 Polymeric/Mixed Micelles 
    5.2.1.2.2 Niosomes   
    5.2.1.2.3 Liposomes   
    5.2.1.2.4 Nanoparticles  
     5.2.1.2.4.1 Nanoemulsions 
     5.2.1.2.4.2 Solid-Lipid Nanoparticles
     5.2.1.2.4.3 Nanosuspensions 
  5.2.2 Conventional Drug Delivery Formulations  
   5.2.2.1 Reconstituted/Lyophilized Formulations 
   5.2.2.2 Emulsions   
   5.2.2.3 Solutions    
   5.2.2.4 Suspensions   
  5.2.3 Long-Acting Injection Formulations  
 5.3 Devices       
  5.3.1 Conventional Injection Devices   
   5.3.1.1 Material    
    5.3.1.1.1 Plastic   
    5.3.1.1.2 Glass   
   5.3.1.2 Usability    
    5.3.1.2.1 Disposable Injection Devices 
    5.3.1.2.2 Reusable Injection Devices 
   5.3.1.3 Product    
    5.3.1.3.1 Prefilled Syringes  
    5.3.1.3.2 Fillable Syringes  
  5.3.2 Self-Injection Devices   
   5.3.2.1 Needle-Free Injectors  
    5.3.2.1.1 Technology   
     5.3.2.1.1.1 Spring-Based Needle-Free Injectors
     5.3.2.1.1.2 Vibration-Based Needle-Free Injectors
     5.3.2.1.1.3 Jet-Based Needle-Free Injectors
     5.3.2.1.1.4 Laser-Powered Needle-Free Injectors
    5.3.2.1.2 Product   
     5.3.2.1.2.1 Prefilled Needle-Free Injectors
     5.3.2.1.2.2 Fillable Needle-Free Injectors
    5.3.2.1.3 Usability   
     5.3.2.1.3.1 Disposable Needle-Free Injectors
     5.3.2.1.3.2 Reusable Needle-Free Injectors
   5.3.2.2 Autoinjectors   
    5.3.2.2.1 Design   
     5.3.2.2.1.1 Customized Autoinjectors
     5.3.2.2.1.2 Standardized Autoinjectors
    5.3.2.2.2 Technology   
     5.3.2.2.2.1 Manual Autoinjectors
     5.3.2.2.2.2 Automated Autoinjectors
    5.3.2.2.3 Product   
     5.3.2.2.3.1 Prefilled Autoinjectors
     5.3.2.2.3.2 Fillable Autoinjectors
    5.3.2.2.4 Usability   
     5.3.2.2.4.1 Disposable Autoinjectors
     5.3.2.2.4.2 Reusable Autoinjectors
   5.3.2.3 Pen Injectors   
    5.3.2.3.1 Design   
     5.3.2.3.1.1 Customized Pen Injectors
     5.3.2.3.1.2 Standard Pen Injectors
    5.3.2.3.2 Product   
     5.3.2.3.2.1 Dual-Chambered Pen Injectors
     5.3.2.3.2.2 Single-Chambered Pen Injectors
    5.3.2.3.3 Usability   
     5.3.2.3.3.1 Disposable Pen Injectors
     5.3.2.3.3.2 Reusable Pen Injectors
   5.3.2.4 Wearable Injectors    
  5.3.3 Integrated safety syringes   
  5.3.4 Patch injectors    
  5.3.5 Safety Syringes    
  5.3.6 Subcutaneous infusion devices   
  5.3.7 Other Devices    
        
6 Global Injectable Drug Delivery Market, By Formulation Packaging 
 6.1 Introduction     
 6.2 Cartridges      
 6.3 Ampules      
 6.4 Bottles      
 6.5 Vials      
        
7 Global Injectable Drug Delivery Market, By Usage Pattern  
 7.1 Introduction     
 7.2 Immunization      
 7.3 Curative Care      
 7.4 Other Usage Patterns    
        
8 Global Injectable Drug Delivery Market, By Facility of Use  
 8.1 Introduction     
 8.2 Home Care Settings     
 8.3 Hospitals and Clinics     
 8.4 Other Facilities of Use    
        
9 Global Injectable Drug Delivery Market, By Site of Administration 
 9.1 Introduction     
 9.2 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
 9.3 Skin (Intradermal and Subcutaneous)    
 9.4 Central Nervous System (Intracerebral and Intrathecal) 
 9.5 Organs (Intravitreal and Intra-Articular)    
        
10 Global Injectable Drug Delivery Market, By Application  
 10.1 Introduction     
 10.2 Hormonal Disorders     
  10.2.1 Anemia     
  10.2.2 Antithrombotic/Thrombolytic Therapy  
  10.2.3 Growth Hormone Deficiency (GHD)  
  10.2.4 Diabetes     
  10.2.5 Osteoporosis    
  10.2.6 Reproductive Health Disease   
 10.3 Autoimmune Diseases    
  10.3.1 Multiple Sclerosis (MS)   
  10.3.2 Psoriasis     
  10.3.3 Rheumatoid Arthritis   
  10.3.4 Crohn’s Disease    
  10.3.5 Other Autoimmune Diseases   
 10.4 Cancer       
 10.5 Orphan Diseases      
 10.6 Cardiovascular diseases    
 10.7 Neurology Addiction    
 10.8 Respiratory Diseases    
 10.9 Regenerative Medicine    
 10.10 Oncology      
 10.11 Other Therapeutic Applications    
  10.11.1 Aesthetic Treatment   
  10.11.2 Pain Management    
  10.11.3 Hemophilia    
  10.11.4 Hepatitis C    
  10.11.5 Allergies     
        
11 Global Injectable Drug Delivery Market, By Distribution Channel  
 11.1 Introduction     
 11.2 Retail Pharmacy Stores    
 11.3 Hospitals      
 11.4 E-Commerce     
        
12 Global Injectable Drug Delivery Market, By End User   
 12.1 Introduction     
 12.2 Ambulatory Care     
 12.3 Home Based     
 12.4 Clinics/Physician Offices    
 12.5 Other End Users     
        
13 Global Injectable Drug Delivery Market, By Geography  
 13.1 Introduction     
 13.2 North America     
  13.2.1 US     
  13.2.2 Canada     
  13.2.3 Mexico     
 13.3 Europe      
  13.3.1 Germany     
  13.3.2 UK     
  13.3.3 Italy     
  13.3.4 France     
  13.3.5 Spain     
  13.3.6 Rest of Europe    
 13.4 Asia Pacific     
  13.4.1 Japan     
  13.4.2 China     
  13.4.3 India     
  13.4.4 Australia     
  13.4.5 New Zealand    
  13.4.6 South Korea    
  13.4.7 Rest of Asia Pacific    
 13.5 South America     
  13.5.1 Argentina    
  13.5.2 Brazil     
  13.5.3 Chile     
  13.5.4 Rest of South America   
 13.6 Middle East & Africa    
  13.6.1 Saudi Arabia    
  13.6.2 UAE     
  13.6.3 Qatar     
  13.6.4 South Africa    
  13.6.5 Rest of Middle East & Africa   
        
14 Key Developments      
 14.1 Agreements, Partnerships, Collaborations and Joint Ventures 
 14.2 Acquisitions & Mergers    
 14.3 New Product Launch    
 14.4 Expansions     
 14.5 Other Key Strategies    
        
15 Company Profiling      
 15.1 Baxter International, Inc.     
 15.2 ELI Lilly and Company     
 15.3 Terumo Corporation     
 15.4 Becton, Dickinson and Company    
 15.5 Pfizer, Inc.      
 15.6 Gerresheimer AG      
 15.7 Teva Pharmaceutical Industries Ltd.   
 15.8 Schott AG      
 15.9 Sandoz        
 15.1 Antares Pharma, Inc.,    
 15.11 Zogenix, Inc.     
 15.12 Scandinavian Health Limited    
 15.13 Terumo Medical Corp.,    
 15.14 Ypsomed Holding AG    
 15.15 Unilife Corporation,     
 15.16 Vetter Pharma-Fertigung GmbH & Co. KG.   
 15.17 Nova Nordisk A/S      

 

Injectable Drug Delivery - Global Market Outlook (2017-2026)

List of Tables       
1 Global Injectable Drug Delivery Market Outlook, By Region (2016-2026) ($MN)
2 Global Injectable Drug Delivery Market Outlook, By Type (2016-2026) ($MN)
3 Global Injectable Drug Delivery Market Outlook, By Formulations  (2016-2026) ($MN)
4 Global Injectable Drug Delivery Market Outlook, By Novel Drug Delivery Formulations (2016-2026) ($MN)
5 Global Injectable Drug Delivery Market Outlook, By Conventional Drug Delivery Formulations (2016-2026) ($MN)
6 Global Injectable Drug Delivery Market Outlook, By Long-Acting Injection Formulations (2016-2026) ($MN)
7 Global Injectable Drug Delivery Market Outlook, By Devices  (2016-2026) ($MN)
8 Global Injectable Drug Delivery Market Outlook, By Conventional Injection Devices (2016-2026) ($MN)
9 Global Injectable Drug Delivery Market Outlook, By Self-Injection Devices (2016-2026) ($MN)
10 Global Injectable Drug Delivery Market Outlook, By Integrated safety syringes (2016-2026) ($MN)
11 Global Injectable Drug Delivery Market Outlook, By Patch injectors (2016-2026) ($MN)
12 Global Injectable Drug Delivery Market Outlook, By Safety Syringes (2016-2026) ($MN)
13 Global Injectable Drug Delivery Market Outlook, By Subcutaneous infusion devices (2016-2026) ($MN)
14 Global Injectable Drug Delivery Market Outlook, By Other Devices (2016-2026) ($MN)
15 Global Injectable Drug Delivery Market Outlook, By Formulation Packaging (2016-2026) ($MN)
16 Global Injectable Drug Delivery Market Outlook, By Cartridges  (2016-2026) ($MN)
17 Global Injectable Drug Delivery Market Outlook, By Ampules (2016-2026) ($MN)
18 Global Injectable Drug Delivery Market Outlook, By Bottles (2016-2026) ($MN)
19 Global Injectable Drug Delivery Market Outlook, By Vials (2016-2026) ($MN)
20 Global Injectable Drug Delivery Market Outlook, By Usage Pattern (2016-2026) ($MN)
21 Global Injectable Drug Delivery Market Outlook, By Immunization  (2016-2026) ($MN)
22 Global Injectable Drug Delivery Market Outlook, By Curative Care  (2016-2026) ($MN)
23 Global Injectable Drug Delivery Market Outlook, By Other Usage Patterns (2016-2026) ($MN)
24 Global Injectable Drug Delivery Market Outlook, By Facility of Use (2016-2026) ($MN)
25 Global Injectable Drug Delivery Market Outlook, By Home Care Settings (2016-2026) ($MN)
26 Global Injectable Drug Delivery Market Outlook, By Hospitals and Clinics  (2016-2026) ($MN)
27 Global Injectable Drug Delivery Market Outlook, By Other Facilities of Use (2016-2026) ($MN)
28 Global Injectable Drug Delivery Market Outlook, By Site of Administration (2016-2026) ($MN)
29 Global Injectable Drug Delivery Market Outlook, By Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)  (2016-2026) ($MN)
30 Global Injectable Drug Delivery Market Outlook, By Skin (Intradermal and Subcutaneous)  (2016-2026) ($MN)
31 Global Injectable Drug Delivery Market Outlook, By Central Nervous System (Intracerebral and Intrathecal) (2016-2026) ($MN)
32 Global Injectable Drug Delivery Market Outlook, By Organs (Intravitreal and Intra-Articular)  (2016-2026) ($MN)
33 Global Injectable Drug Delivery Market Outlook, By Application (2016-2026) ($MN)
34 Global Injectable Drug Delivery Market Outlook, By Hormonal Disorders  (2016-2026) ($MN)
35 Global Injectable Drug Delivery Market Outlook, By Anemia (2016-2026) ($MN)
36 Global Injectable Drug Delivery Market Outlook, By Antithrombotic/Thrombolytic Therapy (2016-2026) ($MN)
37 Global Injectable Drug Delivery Market Outlook, By Growth Hormone Deficiency (GHD) (2016-2026) ($MN)
38 Global Injectable Drug Delivery Market Outlook, By Diabetes (2016-2026) ($MN)
39 Global Injectable Drug Delivery Market Outlook, By Osteoporosis (2016-2026) ($MN)
40 Global Injectable Drug Delivery Market Outlook, By Reproductive Health Disease (2016-2026) ($MN)
41 Global Injectable Drug Delivery Market Outlook, By Autoimmune Diseases (2016-2026) ($MN)
42 Global Injectable Drug Delivery Market Outlook, By Multiple Sclerosis (MS) (2016-2026) ($MN)
43 Global Injectable Drug Delivery Market Outlook, By Psoriasis (2016-2026) ($MN)
44 Global Injectable Drug Delivery Market Outlook, By Rheumatoid Arthritis (2016-2026) ($MN)
45 Global Injectable Drug Delivery Market Outlook, By Crohn’s Disease (2016-2026) ($MN)
46 Global Injectable Drug Delivery Market Outlook, By Other Autoimmune Diseases (2016-2026) ($MN)
47 Global Injectable Drug Delivery Market Outlook, By Cancer  (2016-2026) ($MN)
48 Global Injectable Drug Delivery Market Outlook, By Orphan Diseases  (2016-2026) ($MN)
49 Global Injectable Drug Delivery Market Outlook, By Cardiovascular diseases (2016-2026) ($MN)
50 Global Injectable Drug Delivery Market Outlook, By Neurology Addiction (2016-2026) ($MN)
51 Global Injectable Drug Delivery Market Outlook, By Respiratory Diseases (2016-2026) ($MN)
52 Global Injectable Drug Delivery Market Outlook, By Regenerative Medicine (2016-2026) ($MN)
53 Global Injectable Drug Delivery Market Outlook, By Oncology (2016-2026) ($MN)
54 Global Injectable Drug Delivery Market Outlook, By Other Therapeutic Applications  (2016-2026) ($MN)
55 Global Injectable Drug Delivery Market Outlook, By Aesthetic Treatment (2016-2026) ($MN)
56 Global Injectable Drug Delivery Market Outlook, By Pain Management (2016-2026) ($MN)
57 Global Injectable Drug Delivery Market Outlook, By Hemophilia (2016-2026) ($MN)
58 Global Injectable Drug Delivery Market Outlook, By Hepatitis C (2016-2026) ($MN)
59 Global Injectable Drug Delivery Market Outlook, By Allergies (2016-2026) ($MN)
60 Global Injectable Drug Delivery Market Outlook, By Distribution Channel (2016-2026) ($MN)
61 Global Injectable Drug Delivery Market Outlook, By Retail Pharmacy Stores (2016-2026) ($MN)
62 Global Injectable Drug Delivery Market Outlook, By Hospitals (2016-2026) ($MN)
63 Global Injectable Drug Delivery Market Outlook, By E-Commerce (2016-2026) ($MN)
64 Global Injectable Drug Delivery Market Outlook, By End User (2016-2026) ($MN)
65 Global Injectable Drug Delivery Market Outlook, By Ambulatory Care (2016-2026) ($MN)
66 Global Injectable Drug Delivery Market Outlook, By Home Based (2016-2026) ($MN)
67 Global Injectable Drug Delivery Market Outlook, By Clinics/Physician Offices (2016-2026) ($MN)
68 Global Injectable Drug Delivery Market Outlook, By Other End Users (2016-2026) ($MN)
        
Note: Regional tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are presented in similar manner as the above.

.